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The conversion to a disease-associ-ated conformer (PrPSc) of the cel-
lular prion protein (PrPC) is the central 
event in prion diseases. Wild-type PrPC 
converts to PrPSc in the sporadic forms 
of the disorders through an unknown 
mechanism. These forms account for up 
to 85% of all human (Hu) occurrences; 
the infectious types contribute for less 
than 1%, while genetic incidence of the 
disease is about 15%. Familial Hu prion 
diseases are associated with about 40 
point mutations of the gene coding for 
the PrP denominated PRNP. Most of the 
variants associated with these mutations 
are located in the globular domain of the 
protein. In a recent work in collaboration 
with the German Research School for 
Simulation Science, in Jülich, Germany, 
we performed molecular dynamics simu-
lations for each of these mutants to inves-
tigate their structure in aqueous solution. 
Structural analysis of the various point 
mutations present in the globular 
domain unveiled common folding traits 
that may allow to a better understanding 
of the early conformational changes lead-
ing to the formation of monomeric PrPSc. 
Recent experimental data support these 
findings, thus opening novel approaches 
to determine initial structural determi-
nants of prion formation.
Prion diseases have attracted much atten-
tion from researchers with different sci-
entific backgrounds and coming from 
various areas of expertise. Many questions 
still remain unanswered in the study of 
these rare and yet unique neurodegenera-
tive disorders. Central to understanding 
the disease is deciphering the nature of 
the causative agent of these disorders: the 
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prion. In fact, the mechanism by which a 
prion (PrPSc) is formed and the structure 
of the latter, have posed major challenges 
to this field. Indeed, prion research has 
achieved a great deal of detailed informa-
tion in understanding the pathogenesis of 
the disease, but until now the early events 
leading to the conformational change har-
boring prions have remained elusive.1 In 
an attempt to learning how the protein 
may undergo this conformational rear-
rangement, my group and the group of 
Paolo Carloni at the German Research 
School for Simulation Science, in Jülich, 
Germany, reasoned that some clues might 
come from the study of pathogenic mutants 
in HuPrP. At the time of beginning our 
work the structures of few mutants were 
known.2 The structure of HuPrP was used 
as template for our studies.3 We therefore 
performed molecular dynamics (MD) 
simulations for each of these mutants to 
investigate their structure in aqueous solu-
tion. In total, almost 2 μs MD data were 
obtained. The calculations were based on 
the AMBER(parm99) force field, which 
has been shown to reproduce very accu-
rately the structural features of the wild-
type HuPrP and a few variants for which 
experimental structural information was 
available.4 All the variants present struc-
tural features different from those of wild-
type HuPrP and the protective dominant 
negative polymorphism HuPrP(E219K). 
These characteristics include loss of salt 
bridges in the α
2
-α
3
 regions and the loss of 
π-stacking interactions in the β
2
-α
2
 loop. 
In addition, in the majority of the mutants 
analyzed, the α
3
 helix is more flexible and 
the residue Tyr169 is more exposed to the 
aqueous solvent. The biological relevance 
of these findings is of utmost importance. 
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easily infected by prions, whereas prions 
are poorly transmissible to animals carry-
ing a rigid loop.12 Importantly, horse and 
rabbit have so far displayed resistance to 
prion infections and there are no reports 
of these species developing spontaneous 
prion diseases. NMR studies showed that 
their PrP structures are characterized by 
a rigid β
2
-α
2
 loop and by closer contacts 
between the loop and α
3
 helix.13,14 Thus, 
it seems that prion resistance is enciphered 
by the amino acidic composition of the 
β
2
-α
2
-loop and its long-range interactions 
with the C-terminal end of the α
3
 helix.
Interestingly, it has been proposed 
a role of α
1
 helix as a promoter of PrPC 
aggregation.15 In support, Tyr149 in α
1
 
helix is part of a motif, which may be 
solvent exposed in PrPSc and involved in 
structural rearrangements during fibril 
formation.16 Pronounced stabilization 
of α
1
 helix in the protein may represent 
another important factor in the preven-
tion of spontaneous PrPSc formation.
Comparing the structures of the wild-
type protein and the mutants enabled us 
to detect regions on HuPrP structure that 
may play a key role in the pathogenic con-
version. The obtained structural data indi-
cate that the β
2
-α
2
 loop and, in particular, 
interactions of this loop with residues in 
the C-terminal part of α
3
 helix determine 
the extent of exposure of hydrophobic 
surface to solvent, and thus could influ-
ence propensity of PrPC for intermolecular 
interactions. Moreover, our results high-
light the significance of the α
1
 helix and 
its tertiary contacts in overall stabilization 
of HuPrP folding.
Overall, the many features discussed 
here involve the most important regions 
that confer stability to wild-type HuPrP, 
although the mutations considered are 
different for position and characteristics. 
In particular, the β
2
-α
2
-loop and the α
2
-α
3 
regions are the most affected in terms of 
structural organization and flexibility of 
the molecule. These two subdomains are 
crucial for the stability of the wild-type 
HuPrPC fold17 and might play a prominent 
role in the early unfolding events leading 
to PrPSc conversion.
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The presence of similar traits in this large 
spectrum of mutations hints to a role of 
these characteristics in their known capa-
bilities to generate disease-causing prop-
erties. Overall, we concluded that the 
regions most affected by disease-linked 
mutations in terms of structure and/or 
flexibility might be those involved in the 
pathogenic conversion of PrPC to the scra-
pie form of the protein, and ultimately, in 
the interaction with cellular partners.
Recent reports have indicated that the 
alteration of PRNP sequence by patho-
logical mutations is sufficient to generate 
prions in transgenic mice.5 Therefore, solu-
tion-state NMR studies on PrP mutants 
may help identifying critical regions in 
PrPC structure involved in the conversion. 
The comparison between the structures of 
Q212P and V210I mutants with the wild-
type HuPrP revealed that although struc-
tures share similar globular architecture 
mutations introduce novel local struc-
tural differences.6 The observed variations 
are mostly clustered in the β
2
-α
2
-loop 
region and in the α
2
-α
3
 inter-helical inter-
faces. In contrast to the wild-type pro-
tein, where the structures of Q212P and 
V210I mutants point to the interruption 
of aromatic and hydrophobic interactions 
between residues located at the interface 
of the β
2
-α
2
 loop and the C-terminal end 
of α
3
 helix. A loss of contacts between the 
β
2
-α
2
-loop and the α
3
 helix in the mutants 
results in higher exposure of hydrophobic 
residues to solvent. Similar findings have 
also been reported in the NMR structure 
of the E200K mutant,7 X-ray structures 
of F198S and D178N mutants8 and in 
independent MD studies.9-11 In addition, 
in the two mutants here considered side 
chains of Phe141 and Tyr149 adopt dif-
ferent orientation. Our findings indicate 
that the structural disorder of the β
2
-α
2
-
loop together with the increased distance 
between the loop and α
3
 helix represent 
key pathological structural features and 
may shed light on critical epitopes on the 
HuPrP structure possibly involved in the 
conversion to PrPSc.
Different experimental studies sug-
gested that the conformation of the 
β
2
-α
2
-loop plays a role in the prion disease 
transmission and susceptibility. Several 
studies have indicated that mammals 
carrying a flexible β
2
-α
2
 loop could be 
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